BBA

Baker Bros. Advisors Portfolio holdings

AUM $10.3B
This Quarter Return
+18.16%
1 Year Return
+63.34%
3 Year Return
+231.6%
5 Year Return
+293.68%
10 Year Return
+1,612.7%
AUM
$9.8B
AUM Growth
+$9.8B
Cap. Flow
+$744M
Cap. Flow %
7.6%
Top 10 Hldgs %
73.27%
Holding
122
New
14
Increased
15
Reduced
12
Closed
1

Top Buys

1
AVNR
AVANIR PHARMACEUTICALS, INC CL A
AVNR
$297M
2
SGEN
Seagen Inc. Common Stock
SGEN
$173M
3
BMRN icon
BioMarin Pharmaceuticals
BMRN
$121M
4
BLCM
Bellicum Pharmaceuticals, Inc.
BLCM
$98.7M
5
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
$72M

Top Sells

1
PCYC
PHARMACYCLICS INC
PCYC
$64.5M
2
XOMA icon
Xoma
XOMA
$22.1M
3
AMBI
AMBIT BIOSCIENCES CORP COM STK (DE)
AMBI
$16.8M
4
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$15.4M
5
RPRX
Repros Therapeutics Inc.
RPRX
$7.76M

Sector Composition

1 Healthcare 42.14%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
PCYC
1
DELISTED
PHARMACYCLICS INC
PCYC
$1.12B 11.39% 9,129,231 -527,368 -5% -$64.5M
INCY icon
2
Incyte
INCY
$16.5B
$1.09B 11.08% 14,845,559 – –
GEVA
3
DELISTED
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
$989M 10.1% 10,660,432 – –
SGEN
4
DELISTED
Seagen Inc. Common Stock
SGEN
$895M 9.14% 27,861,720 +5,385,991 +24% +$173M
AVNR
5
DELISTED
AVANIR PHARMACEUTICALS, INC CL A
AVNR
$653M 6.66% 38,513,713 +17,539,036 +84% +$297M
ACAD icon
6
Acadia Pharmaceuticals
ACAD
$4.38B
$650M 6.64% 20,481,442 – –
GHDX
7
DELISTED
Genomic Health, Inc.
GHDX
$437M 4.46% 13,656,318 +700 +0% +$22.4K
BMRN icon
8
BioMarin Pharmaceuticals
BMRN
$11.2B
$336M 3.43% 3,713,950 +1,343,486 +57% +$121M
ANAC
9
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
$136M 1.38% 4,204,702 – –
BCRX icon
10
BioCryst Pharmaceuticals
BCRX
$1.74B
$130M 1.33% 10,713,686 – –
BLCM
11
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$98.7M 1.01% +4,283,732 New +$98.7M
DYAX
12
DELISTED
DYAX CORPORATION
DYAX
$86.6M 0.88% 6,157,789 – –
CERS icon
13
Cerus
CERS
$251M
$73M 0.75% 11,702,727 -237,451 -2% -$1.48M
SLXP
14
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
$73M 0.75% 635,321 +626,700 +7,269% +$72M
VNDA icon
15
Vanda Pharmaceuticals
VNDA
$279M
$64M 0.65% 4,472,153 +100,000 +2% +$1.43M
XOMA icon
16
Xoma
XOMA
$392M
$60.8M 0.62% 16,924,013 -6,147,459 -27% -$22.1M
XNPT
17
DELISTED
XENOPORT, INC.
XNPT
$60.5M 0.62% 6,903,628 +87,851 +1% +$770K
ARAV
18
DELISTED
Aravive, Inc. Common Stock
ARAV
$51.2M 0.52% 2,281,744 +1,035,655 +83% +$23.3M
MRTX
19
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$44.1M 0.45% 2,380,074 – –
DBVT
20
DBV Technologies
DBVT
$264M
$41.2M 0.42% +1,519,229 New +$41.2M
PGNX
21
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$33.6M 0.34% 4,449,797 – –
DSCI
22
DELISTED
Derma Sciences, Inc. Common Stock (DE)
DSCI
$32.9M 0.34% 3,537,137 – –
TGTX icon
23
TG Therapeutics
TGTX
$4.65B
$32.5M 0.33% 2,050,313 – –
ACOR
24
DELISTED
Acorda Therapeutics, Inc.
ACOR
$30.9M 0.32% 755,534 +2,143 +0.3% +$87.6K
HALO icon
25
Halozyme
HALO
$8.56B
$26.8M 0.27% 2,776,143 – –
1
2 3 4 5